D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Price:
15 060
KRW
0.47%
Market Closed
Market Cap:
669.6B
KRW
Income Statement
Earnings Waterfall
Dongkook Pharmaceutical Co Ltd
Dongkook Pharmaceutical Co Ltd
|
Revenue
|
812.2B
KRW
|
|
Cost of Revenue
|
-364.3B
KRW
|
|
Gross Profit
|
447.9B
KRW
|
|
Operating Expenses
|
-367.5B
KRW
|
|
Operating Income
|
80.4B
KRW
|
|
Other Expenses
|
-19.2B
KRW
|
|
Net Income
|
61.2B
KRW
|
Income Statement
Dongkook Pharmaceutical Co Ltd
Dongkook Pharmaceutical Co Ltd
Currency: KRW
Millions
TTM
| Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
226 015
N/A
|
228 198
+1%
|
234 687
+3%
|
244 766
+4%
|
259 930
+6%
|
275 174
+6%
|
292 760
+6%
|
302 007
+3%
|
309 690
+3%
|
320 349
+3%
|
330 629
+3%
|
342 293
+4%
|
354 768
+4%
|
366 905
+3%
|
378 387
+3%
|
391 800
+4%
|
400 807
+2%
|
418 583
+4%
|
436 293
+4%
|
456 230
+5%
|
482 280
+6%
|
502 390
+4%
|
520 469
+4%
|
544 685
+5%
|
559 103
+3%
|
572 390
+2%
|
588 359
+3%
|
585 740
0%
|
594 193
+1%
|
615 974
+4%
|
631 065
+2%
|
645 744
+2%
|
661 647
+2%
|
676 772
+2%
|
692 794
+2%
|
709 543
+2%
|
730 994
+3%
|
747 013
+2%
|
764 673
+2%
|
789 114
+3%
|
812 166
+3%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(98 041)
|
(99 097)
|
(102 533)
|
(105 870)
|
(111 578)
|
(115 214)
|
(120 762)
|
(124 611)
|
(126 781)
|
(132 120)
|
(136 043)
|
(139 273)
|
(145 412)
|
(151 522)
|
(155 139)
|
(160 383)
|
(162 858)
|
(169 097)
|
(175 871)
|
(183 440)
|
(191 445)
|
(198 389)
|
(205 265)
|
(213 813)
|
(221 694)
|
(227 674)
|
(236 998)
|
(240 243)
|
(243 933)
|
(256 244)
|
(264 210)
|
(270 754)
|
(281 822)
|
(291 152)
|
(300 870)
|
(310 064)
|
(320 213)
|
(327 915)
|
(337 031)
|
(350 035)
|
(364 270)
|
|
| Gross Profit |
127 974
N/A
|
129 100
+1%
|
132 153
+2%
|
138 895
+5%
|
148 352
+7%
|
159 959
+8%
|
171 997
+8%
|
177 395
+3%
|
182 909
+3%
|
188 229
+3%
|
194 585
+3%
|
203 019
+4%
|
209 356
+3%
|
215 382
+3%
|
223 248
+4%
|
231 417
+4%
|
237 949
+3%
|
249 486
+5%
|
260 422
+4%
|
272 789
+5%
|
290 835
+7%
|
304 000
+5%
|
315 203
+4%
|
330 872
+5%
|
337 410
+2%
|
344 717
+2%
|
351 362
+2%
|
345 497
-2%
|
350 260
+1%
|
359 730
+3%
|
366 856
+2%
|
374 990
+2%
|
379 826
+1%
|
385 620
+2%
|
391 925
+2%
|
399 479
+2%
|
410 781
+3%
|
419 099
+2%
|
427 641
+2%
|
439 079
+3%
|
447 896
+2%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(101 419)
|
(103 360)
|
(106 595)
|
(110 589)
|
(114 742)
|
(122 305)
|
(127 942)
|
(132 136)
|
(135 983)
|
(140 092)
|
(148 179)
|
(155 887)
|
(159 285)
|
(163 740)
|
(168 995)
|
(173 386)
|
(182 834)
|
(192 595)
|
(201 971)
|
(212 383)
|
(222 250)
|
(230 591)
|
(238 519)
|
(247 048)
|
(252 676)
|
(259 708)
|
(268 824)
|
(276 682)
|
(287 041)
|
(292 709)
|
(295 660)
|
(303 468)
|
(307 172)
|
(317 064)
|
(330 422)
|
(335 645)
|
(343 908)
|
(350 521)
|
(352 750)
|
(355 849)
|
(367 476)
|
|
| Selling, General & Administrative |
(91 193)
|
(92 722)
|
(95 877)
|
(99 947)
|
(104 265)
|
(111 161)
|
(117 152)
|
(121 475)
|
(125 188)
|
(130 082)
|
(137 271)
|
(143 713)
|
(145 976)
|
(148 815)
|
(152 719)
|
(157 349)
|
(165 834)
|
(174 923)
|
(182 535)
|
(190 249)
|
(199 245)
|
(207 045)
|
(215 523)
|
(224 472)
|
(230 420)
|
(237 354)
|
(245 591)
|
(249 859)
|
(258 083)
|
(261 987)
|
(263 937)
|
(273 431)
|
(279 435)
|
(289 111)
|
(301 649)
|
(306 898)
|
(312 714)
|
(317 656)
|
(318 860)
|
(320 341)
|
(329 655)
|
|
| Research & Development |
(9 620)
|
(10 089)
|
(10 161)
|
(10 178)
|
(10 099)
|
(10 801)
|
(10 470)
|
(10 312)
|
(10 415)
|
(9 621)
|
(10 500)
|
(11 730)
|
(12 788)
|
(14 287)
|
(15 531)
|
(15 186)
|
(15 960)
|
(16 044)
|
(17 273)
|
(19 407)
|
(19 890)
|
(20 445)
|
(19 883)
|
(19 468)
|
(18 859)
|
(18 877)
|
(19 590)
|
(22 519)
|
(24 691)
|
(26 376)
|
(27 156)
|
(25 748)
|
(23 105)
|
(23 036)
|
(23 600)
|
(23 514)
|
(25 456)
|
(26 786)
|
(27 439)
|
(28 482)
|
(30 325)
|
|
| Depreciation & Amortization |
(606)
|
(549)
|
(557)
|
(463)
|
(379)
|
(344)
|
(322)
|
(352)
|
(380)
|
(393)
|
(412)
|
(448)
|
(522)
|
(642)
|
(749)
|
(854)
|
(1 040)
|
(1 630)
|
(2 165)
|
(2 729)
|
(3 115)
|
(3 104)
|
(3 115)
|
(3 111)
|
(3 398)
|
(3 509)
|
(3 665)
|
(4 329)
|
(4 266)
|
(4 346)
|
(4 567)
|
(4 288)
|
(4 632)
|
(4 917)
|
(5 173)
|
(5 233)
|
(5 738)
|
(6 078)
|
(6 452)
|
(7 026)
|
(7 496)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
4
|
4
|
4
|
0
|
4
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
3
|
0
|
32
|
23
|
25
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
26 553
N/A
|
25 739
-3%
|
25 557
-1%
|
28 305
+11%
|
33 610
+19%
|
37 653
+12%
|
44 054
+17%
|
45 259
+3%
|
46 926
+4%
|
48 137
+3%
|
46 406
-4%
|
47 132
+2%
|
50 071
+6%
|
51 642
+3%
|
54 253
+5%
|
58 031
+7%
|
55 115
-5%
|
56 890
+3%
|
58 450
+3%
|
60 405
+3%
|
68 585
+14%
|
73 409
+7%
|
76 684
+4%
|
83 824
+9%
|
84 734
+1%
|
85 009
+0%
|
82 539
-3%
|
68 815
-17%
|
63 219
-8%
|
67 021
+6%
|
71 195
+6%
|
71 522
+0%
|
72 654
+2%
|
68 556
-6%
|
61 503
-10%
|
63 834
+4%
|
66 873
+5%
|
68 578
+3%
|
74 891
+9%
|
83 230
+11%
|
80 420
-3%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
1 389
|
1 339
|
2 058
|
1 744
|
1 742
|
1 641
|
1 257
|
3 252
|
5 814
|
4 558
|
5 102
|
3 573
|
952
|
2 585
|
3 325
|
2 971
|
6 868
|
6 887
|
6 601
|
8 097
|
5 120
|
7 087
|
6 361
|
5 155
|
(446)
|
(2 007)
|
(2 916)
|
(1 844)
|
7 142
|
5 447
|
4 819
|
5 431
|
(3 915)
|
(1 793)
|
(1 568)
|
(2 471)
|
(4 939)
|
(1 132)
|
(2 155)
|
668
|
9 434
|
|
| Non-Reccuring Items |
(389)
|
(387)
|
(112)
|
(111)
|
(13)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
(12)
|
(12)
|
(11)
|
(12)
|
(12)
|
(12)
|
(11)
|
(189)
|
(189)
|
(189)
|
(11)
|
165
|
165
|
165
|
(11)
|
(12)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
58
|
26
|
22
|
11
|
11
|
(4)
|
15
|
15
|
22
|
0
|
0
|
8
|
331
|
436
|
539
|
506
|
432
|
327
|
244
|
276
|
(341)
|
(338)
|
(369)
|
(365)
|
(2)
|
(77)
|
(68)
|
(70)
|
966
|
1 630
|
1 659
|
1 656
|
619
|
26
|
(1)
|
751
|
753
|
753
|
849
|
99
|
100
|
|
| Total Other Income |
800
|
875
|
925
|
721
|
1 441
|
1 483
|
1 530
|
1 588
|
1 382
|
1 234
|
1 243
|
1 100
|
1 448
|
1 248
|
1 067
|
654
|
703
|
1 012
|
1 556
|
2 381
|
2 276
|
2 243
|
880
|
176
|
(4 243)
|
(4 723)
|
(4 673)
|
(3 816)
|
(1 574)
|
(2 494)
|
(2 349)
|
(2 793)
|
(725)
|
(427)
|
(615)
|
(2 021)
|
(1 850)
|
(2 685)
|
(2 350)
|
(1 229)
|
(5 216)
|
|
| Pre-Tax Income |
28 411
N/A
|
27 591
-3%
|
28 450
+3%
|
30 670
+8%
|
36 791
+20%
|
40 763
+11%
|
46 845
+15%
|
50 103
+7%
|
54 133
+8%
|
53 917
0%
|
52 739
-2%
|
51 801
-2%
|
52 790
+2%
|
55 901
+6%
|
59 172
+6%
|
62 150
+5%
|
63 107
+2%
|
64 927
+3%
|
66 663
+3%
|
70 970
+6%
|
75 629
+7%
|
82 566
+9%
|
83 722
+1%
|
88 957
+6%
|
80 031
-10%
|
78 190
-2%
|
74 882
-4%
|
63 086
-16%
|
69 754
+11%
|
71 605
+3%
|
75 324
+5%
|
75 816
+1%
|
68 632
-9%
|
66 361
-3%
|
59 319
-11%
|
60 093
+1%
|
60 838
+1%
|
65 514
+8%
|
71 235
+9%
|
82 768
+16%
|
84 738
+2%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(7 414)
|
(6 930)
|
(7 036)
|
(7 618)
|
(9 564)
|
(10 387)
|
(11 745)
|
(12 036)
|
(13 440)
|
(13 480)
|
(12 848)
|
(12 697)
|
(11 923)
|
(12 511)
|
(13 478)
|
(14 242)
|
(13 674)
|
(13 054)
|
(13 586)
|
(14 507)
|
(16 579)
|
(19 544)
|
(19 556)
|
(22 768)
|
(22 150)
|
(22 008)
|
(21 509)
|
(19 209)
|
(16 837)
|
(18 309)
|
(17 130)
|
(14 009)
|
(13 876)
|
(11 292)
|
(10 133)
|
(10 397)
|
(11 966)
|
(12 779)
|
(15 933)
|
(18 717)
|
(22 401)
|
|
| Income from Continuing Operations |
20 997
|
20 661
|
21 414
|
23 052
|
27 227
|
30 376
|
35 100
|
38 068
|
40 693
|
40 438
|
39 891
|
39 103
|
40 868
|
43 389
|
45 695
|
47 909
|
49 433
|
51 874
|
53 077
|
56 463
|
59 050
|
63 022
|
64 166
|
66 188
|
57 880
|
56 181
|
53 372
|
43 878
|
52 916
|
53 296
|
58 194
|
61 808
|
54 757
|
55 069
|
49 186
|
49 696
|
48 871
|
52 734
|
55 302
|
64 050
|
62 336
|
|
| Income to Minority Interest |
101
|
149
|
(34)
|
87
|
199
|
113
|
92
|
34
|
(33)
|
(15)
|
107
|
(1 032)
|
(1 266)
|
(1 695)
|
(2 824)
|
(2 215)
|
(2 484)
|
(2 717)
|
(2 459)
|
(2 666)
|
(2 738)
|
(2 662)
|
(2 596)
|
(2 686)
|
(1 955)
|
(1 665)
|
(888)
|
67
|
(2 571)
|
(2 376)
|
(2 583)
|
(2 864)
|
(1 861)
|
(1 839)
|
(2 029)
|
(2 222)
|
(1 696)
|
(1 910)
|
(810)
|
(2 396)
|
(1 117)
|
|
| Net Income (Common) |
21 098
N/A
|
20 810
-1%
|
21 379
+3%
|
23 139
+8%
|
27 426
+19%
|
30 488
+11%
|
35 192
+15%
|
38 100
+8%
|
40 660
+7%
|
40 421
-1%
|
39 996
-1%
|
38 070
-5%
|
39 602
+4%
|
41 695
+5%
|
42 872
+3%
|
45 695
+7%
|
46 949
+3%
|
49 157
+5%
|
50 618
+3%
|
53 797
+6%
|
56 312
+5%
|
60 360
+7%
|
61 569
+2%
|
63 501
+3%
|
55 925
-12%
|
54 515
-3%
|
52 484
-4%
|
43 945
-16%
|
50 345
+15%
|
50 919
+1%
|
55 611
+9%
|
58 943
+6%
|
52 896
-10%
|
53 230
+1%
|
47 157
-11%
|
47 474
+1%
|
47 175
-1%
|
50 824
+8%
|
54 492
+7%
|
61 654
+13%
|
61 219
-1%
|
|
| EPS (Diluted) |
479.5
N/A
|
472.95
-1%
|
485.88
+3%
|
525.88
+8%
|
623.31
+19%
|
692.9
+11%
|
799.81
+15%
|
865.9
+8%
|
924.09
+7%
|
918.65
-1%
|
909
-1%
|
865.22
-5%
|
900.04
+4%
|
947.61
+5%
|
974.36
+3%
|
1 038.52
+7%
|
1 067.02
+3%
|
1 092.37
+2%
|
1 124.84
+3%
|
1 195.48
+6%
|
1 251.37
+5%
|
1 341.33
+7%
|
1 368.2
+2%
|
1 411.13
+3%
|
1 242.77
-12%
|
1 211.44
-3%
|
1 173.64
-3%
|
982.69
-16%
|
1 125.82
+15%
|
1 138.65
+1%
|
1 243.39
+9%
|
1 317.88
+6%
|
1 182.73
-10%
|
1 190.15
+1%
|
1 054.2
-11%
|
1 061.28
+1%
|
1 054.64
-1%
|
1 136.17
+8%
|
1 218
+7%
|
1 378.09
+13%
|
1 368.41
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
